Galapagos NV

BOVESPA:G1LP34 Stock Report

Market Cap: R$11.2b

Galapagos Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Paul Stoffels

Chief executive officer

€2.0m

Total compensation

CEO salary percentage38.0%
CEO tenure2.7yrs
CEO ownershipn/a
Management average tenure2.6yrs
Board average tenure2.7yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Paul Stoffels's remuneration changed compared to Galapagos's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-€61m

Jun 30 2024n/an/a

€32m

Mar 31 2024n/an/a

€31m

Dec 31 2023€2m€750k

-€4m

Sep 30 2023n/an/a

-€153m

Jun 30 2023n/an/a

-€46m

Mar 31 2023n/an/a

-€69m

Dec 31 2022€1m€563k

-€71m

Compensation vs Market: Paul's total compensation ($USD2.06M) is above average for companies of similar size in the BR market ($USD682.78K).

Compensation vs Earnings: Paul's compensation has increased whilst the company is unprofitable.

CEO

Paul Stoffels (62 yo)

2.7yrs

Tenure

€1,971,286

Compensation

Dr. Paulus A. Stoffels, also known as Paul, Ph.D. M.D. is Chief Executive Officer of Galapagos NV since April 01, 2022 and also serves as its Chairman since April 26, 2022 and also serves as its Interim He...

Leadership Team

NamePositionTenureCompensationOwnership
Paulus Stoffels
CEO, Chairman2.7yrs€1.97mno data
Thad Huston
Executive VP1.4yrsno datano data
Sofie Van Gijsel
Head of Investor Relationsno datano datano data
Valeria Cnossen
Executive VP & General Counsel2.9yrsno datano data
Marieke Vermeersch
Head of Corporate Communicationno datano datano data
Annelies Missotten
Executive VP & Chief Human Resources Officerno datano datano data
Ellen Aar
Head of Developmentno datano datano data
Philippe Alen
Senior VP & Head of Business Development2.9yrsno datano data
Alice Dietrich
Head of Medical Affairsno datano datano data
Pierre Raboisson
Head of Small Molecules Discovery & Senior VP2.5yrsno datano data
Patrik Ringblom
Head of Strategy & US Lead1.2yrsno datano data
Jeevan Shetty
Head of Clinical Development Oncologyno datano datano data

2.6yrs

Average Tenure

52.5yo

Average Age

Experienced Management: G1LP34's management team is considered experienced (2.6 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Paulus Stoffels
CEO, Chairman2.7yrs€1.97mno data
Simon Sturge
Independent Non-Executive Director1.3yrs€32.37k0.00027%
R$ 30.1k
Jerome Contamine
Lead Independent Non-Executive Director2.7yrs€150.00k0.0015%
R$ 170.7k
Andrew Dickinson
Non-Executive Non-Independent Directorless than a yearno datano data
Linda Higgins
Non-Executive Non-Independent Director5.2yrsno datano data
Susanne Schaffert
Non-Executive Independent Director1.5yrs€59.85k0.00055%
R$ 61.4k
Oleg Nodelman
Non-Executive Non-Independent Directorless than a yearno datano data
Peter Guenter
Independent Non-Executive Director5.7yrs€115.00k0.0030%
R$ 337.0k
Elisabeth Svanberg
Independent Non-Executive Director4.7yrs€138.75k0.0029%
R$ 319.2k

2.7yrs

Average Tenure

62yo

Average Age

Experienced Board: G1LP34's board of directors are not considered experienced ( 2.7 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/27 23:38
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Galapagos NV is covered by 34 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
René VerhoefABN AMRO Bank N.V.
Emily FieldBarclays
Patrick TrucchioBerenberg